AI startup Overworld has released Waypoint-1.5, an update to its real-time world simulation system that generates interactive 3D worlds on consumer hardware. The software now runs on Mac and Windows ...
AI development company Black Forest Labs released ' FLUX.2 Small Decoder, ' a high-speed decoder for the FLUX.2 series, on April 8, 2026. black-forest-labs/FLUX.2 ...
Microsoft says Agent Framework 1.0 is the production-ready release, with stable APIs and long-term support for both .NET and Python. The framework is presented as a unified successor path that builds ...
Google has unveiled Gemini 3.1 Flash Live, its best voice and audio AI model yet. It delivers faster responses, more natural conversations, and configurable thinking levels for developers. Google says ...
The TeamPCP hacking group continues its supply-chain rampage, now compromising the massively popular "LiteLLM" Python package on PyPI and claiming to have stolen data from hundreds of thousands of ...
And now for something completely different! This week, we're celebrating the work of Monty Python. One of the most influential sketch groups of all time. This special episode features interviews from ...
Curious how the Caesar Cipher works? This Python tutorial breaks it down in a simple, beginner-friendly way. Learn how to encode and decode messages using one of the oldest and most famous encryption ...
The New York Times’ daily puzzle Wordle continues to be one of the most widely played online word games, challenging millions of users every morning with a fresh five-letter riddle. As players log in ...
The creator of the Kryptos panels, Jim Sanborn, sought to unburden himself of the puzzle, and then discovered before an auction he had archived its solution in the Smithsonian. By John Schwartz John ...
A price has been set for one of the biggest secrets kept by the United States’ top spy agency: $962,500. That was the price reached at a Thursday auction of the solution to the last bit of the ...
Data from the Phase III FINE-ONE trial, which investigated the safety and efficacy of finerenone versus placebo in adults with type 1 diabetes (T1D) and chronic kidney disease (CKD), will be featured ...